Los Angeles, CA, United States of America

Andrew E Pelling

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2013.


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andrew E Pelling: Innovator in Cell Characterization Technologies

Introduction

Andrew E Pelling is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of cell characterization through his innovative methods and devices. His work focuses on understanding cell characteristics, which has important implications for drug screening and diagnostics.

Latest Patents

Pelling holds a patent titled "Methods and devices for determining a cell characteristic, and applications employing the same." This invention provides methods for determining various characteristics of a cell, such as cell type and cellular response to biochemical events. The method involves detecting membrane movement in a cell to ascertain its characteristics. The applications of this invention are particularly useful in drug screening and diagnostics, and it includes databases of cell characteristics determined by these methods.

Career Highlights

Andrew E Pelling is affiliated with the University of California, where he continues to advance research in cell biology and biotechnology. His work has garnered attention for its potential to revolutionize how we understand and interact with cellular processes.

Collaborations

Pelling has collaborated with James K Gimzewski, further enhancing the research and development of innovative technologies in the field of cell characterization.

Conclusion

Andrew E Pelling's contributions to cell characterization technologies highlight the importance of innovation in the life sciences. His work not only advances scientific understanding but also paves the way for practical applications in medicine and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…